All In Biotech

Drug Trial Radar · NCT04068051

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

An Open-Label, Long-Term Study to Assess the Safety and Efficacy of AXS-07 (MoSEIC™ Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults

Last checked: Nov 19, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

706

Actual

Start

Jul 6, 2019

Primary completion

Sep 22, 2020

Study completion Sep 22, 2020

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Aug 28, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

MOVEMENT (Multimechanistic Treatment over Time of Migraine Symptoms) is a Phase 3 study to evaluate the long-term safety of chronic intermittent use of AXS-07 and to assess the effect of AXS-07 on migraine symptoms following repeated treatment of migraine attacks.

Conditions

  • Migraine

Interventions

  • AXS-07Drug

    AXS-07 (MoSEIC meloxicam and rizatriptan) taken by mouth for the acute treatment of migraine.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Long-term Safety of Chronic Intermittent Use of AXS-07Time frame: Up to 12 months

Locations

51 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Site

    Birmingham, Alabama

  • Clinical Research Site

    Birmingham, Alabama

  • Clinical Research Site

    Mobile, Alabama

  • Clinical Research Site

    Phoenix, Arizona

  • Clinical Research Site

    Canoga Park, California

  • Clinical Research Site

    Colton, California

  • Clinical Research Site

    Encino, California

  • Clinical Research Site

    Los Alamitos, California

  • Clinical Research Site

    Los Angeles, California

  • Clinical Research Site

    Los Angeles, California

  • Clinical Research Site

    San Diego, California

  • Clinical Research Site

    Spring Valley, California

  • Clinical Research Site

    Walnut Creek, California

  • Clinical Research Site

    Hallandale, Florida

  • Clinical Research Site

    Jacksonville, Florida

  • Clinical Research Site

    Lake City, Florida

  • Clinical Research Site

    Lake Worth, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Ocoee, Florida

  • Clinical Research Site

    Orlando, Florida

  • Clinical Research Site

    Ormond Beach, Florida

  • Clinical Research Site

    Tampa, Florida

  • Clinical Research Site

    Stockbridge, Georgia

  • Clinical Research Site

    Evanston, Illinois

  • Clinical Research Site

    Louisville, Kentucky

  • Clinical Research Site

    Boston, Massachusetts

  • Clinical Research Site

    North Dartmouth, Massachusetts

  • Clinical Research Site

    Waltham, Massachusetts

  • Clinical Research Site

    Ann Arbor, Michigan

  • Clinical Research Site

    Minneapolis, Minnesota

  • Clinical Research Site

    Springfield, Missouri

  • Clinical Research Site

    Las Vegas, Nevada

  • Clinical Research Site

    Albuquerque, New Mexico

  • Clinical Research Site

    Manlius, New York

  • Clinical Research Site

    Rochester, New York

  • Clinical Research Site

    Williamsville, New York

  • Clinical Research Site

    High Point, North Carolina

  • Clinical Research Site

    Cincinnati, Ohio

  • Clinical Research Site

    Columbus, Ohio

  • Clinical Research Site

    Oklahoma City, Oklahoma

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.